Blog
NGS Workflows: A Simpler Life Through Software
BlogHaving too much data sounds like a nice problem to have. But Next Generation Sequencing (NGS) data’s ubiquity poses challenges as well as opportunities for geneticists. Quick, accurate and reliable workflows are top of the average geneticist’s wishlist. We caught up with OGT’s Dave Cook to discuss the challenges of NGS data, and how software can make things simpler.
Read More
The Digital Solutions Offering Complete Control over Bioprocessing Workflows
BlogRobust data management is integral to both academic researchers and scientists in the pharmaceutical industry, especially for those working with bioprocessing workflows. In this blog, Thermo Fisher Scientific’s Karen Velardi explains how the introduction of digital science solutions to the modern lab is transforming bioprocessing workflows by providing scientists with full control over procedures, data integrity and compliance
Read More
Moving Past Paper: Realizing the Potential of ELNs
BlogElectronic Laboratory Notebooks are becoming more popular as labs embrace digitization. ELN provider Biodata’s flagship offering, Labguru, has over 30,000 users worldwide. We caught up with Steve Yemm, recently appointed CEO of BioData, to ask him about the advantages of ELNs and the challenges they face in a digital market.
The Digital Solutions Accelerating Scientific Discovery
BlogScience advances at a rapid pace, and supporting technologies and infrastructures have to adapt accordingly. One of the latest evolutions in technology is the shift from traditional software and hardware tools to newer cloud-based services. In this blog, Thermo Fisher Scientific's Karen Velardi looks at, we look at the different cloud services that are changing the way modern research is done.
Read More
More Tools and More Time: An Easier Future for Bioinformaticians?
BlogIn the second of a two-part blog series, we talk with Genestack CEO Misha Kapushesky on the developments in Bioinformatics that he’s most excited about, and the latest modular additions to Genestack's bioinformatics platform.
Read More
Are Modular Approaches The Way Forward for Bioinformatics?
BlogIn the first of a two-part blog series, we discuss the advantages of a modular approach to bioinformatics with Dr. Misha Kapushesky, CEO and Founder of Genestack. Perviously a Team Leader at the European Bioinformatics Institute, we also learn about Misha's move from Institute to industry.
Read More
Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis
BlogTo learn more about ContextVision, their move into the field of digital pathology, and how INIFY™ could help benefit pathologists and patients, we spoke to Lena Kajland Wilén, Director Business Unit Digital Pathology.
Read More
Cloud Robotics Advances Data in Biological Research
BlogThe Defense Advanced Research Projects Agency’s (DARPA) Synergistic Discovery and Design Program (SD2) hopes to update protocols with enhanced automation and machine learning strategies. As part of SD2, Ginkgo Bioworks, and Transcriptic have been offered a dual contract to help advance biological experimentation and iterative testing for synthetic biology. In this blog, we discuss the goals of SD2 and the impact of automation on research with Ben Miles, PhD, Head of Product at Transcriptic.
Read More
Preparing Laboratories for the Digital Revolution
BlogDigital transformation, often described as the next industrial revolution, has already begun to permanently change almost every aspect of our lives.
Science, of course, is no exception. Digital transformation is poised to fundamentally change how scientists conduct research and how laboratories operate. But, what is the current state of digitalization within today’s labs, and how can they ensure they are ready for digital transformation?
Using Cell-free DNA as a Marker for Liver Cancer Diagnosis
BlogDuring this year’s AACR conference we spoke to Kang Zhang, M.D., Ph.D. from the University of California, San Diego about the collaborative work he has been doing with the Laboratory for Advanced Medicine. He discusses their recent study findings on the use of a blood-based method to look at cell-free DNA as a marker for liver cancer diagnosis and prognosis.
Read More
